Inventor · disambiguated record
Lina Q. Setti
Also filed as: SETTI LINA · SETTI LINA Q · SETTI LINA QUATTROCCHIO
12 granted patents·4 pending applications·54 citations·filing 2002–2023
88Inventor score
Top patents by PatentIndex Score
16 records- 0194US9242969B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Jan 26, 2016·35 cites·17 claims
- 0289US10709712B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Jul 14, 2020·3 cites·7 claims
- 0384US10245267B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Apr 2, 2019·3 cites·4 claims
- 0484US9694016B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Jul 4, 2017·5 cites·8 claims
- 0582US10167279B2Compounds and compositions as RAF kinase inhibitorsNOVARTIS AG·Filed 2015·Granted Jan 1, 2019·3 cites·17 claims
- 0679US11254651B2Histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Feb 22, 2022·2 cites·20 claims
- 0771US11566030B2Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Granted Jan 31, 2023·0 cites·31 claims
- 0868US2023151016A1Pyrrolidine-pyrazoles as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0966US9695166B2Pyrazolopyridine pyrazolopyrimidine and related compoundsGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Jul 4, 2017·1 cites·40 claims
- 1064US6642381B2Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitorsHOFFMANN LA ROCHE·Filed 2002·Granted Nov 4, 2003·2 cites·17 claims
- 1157US2024408107A1Lactam pyrrolidine-pyrazoles as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1256US10144746B2Bridged bicyclic kallikrein inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·0 cites·17 claims
- 1354US2023159538A1Pyrrolidine-pyrazoles as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1453US9815853B2Bridged bicyclic kallikrein inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2017·0 cites·16 claims
- 1552US2023278984A1Urea derivatives as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1643US11584734B2Tricyclic compounds as histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Feb 21, 2023·0 cites·45 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →